Connect with NCQA

twitter linkedin facebook google+ youtube pinterest

Report an Error

Use NCQA’s Feedback Form to report a broken link, or content error.

Use of Spirometry Testing in the Assessment and Diagnosis of COPD

This HEDIS Measure

Assesses adults 40 years of age and older who have a new diagnosis of chronic obstructive pulmonary disease (COPD) or newly active COPD, who received spirometry testing to confirm the diagnosis.

So What?

COPD is a progressive, irreversible respiratory condition and is the third leading cause of the death in the United States.1,2 Spirometry testing is recommended by the Global Initiative for Chronic Obstructive Lung Disease as the preferred method for diagnosing COPD.2 Despite being the gold standard for diagnosis and assessment of COPD, spirometry testing is underused. Earlier diagnosis using spirometry testing supports a treatment plan that may protect against worsening symptoms and decrease the number of exacerbations.

References

1.      Hoyert, D., and J. Xu. 2012. “Deaths: Preliminary Data for 2011.” National Vital Statistics Reports 61(6):1-52. http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_06.pdf

2.      Global Initiative for Chronic Obstructive Lung Disease. 2014. “Global Strategy for the Diagnosis, and Prevention of Chronic Obstructive Pulmonary Disease.” 

tables
Spirometry Testing Rate
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 42.0 40.5 31.6 34.9 35.0
2015 43.4 41.1 31.0 36.3 36.6
2014 43.0 41.2 31.0 36.3 35.0
2013 42.5 41.0 31.0 36.0 35.6
2012 43.5 41.5 31.5 36.8 35.0
2011 42.9 40.5 32.0 36.3 35.6
2010 41.7 40.2 31.3 33.9 35.3
2009 38.8 36.7 28.6 28.5 28.8
2008 37.6 36.4 29.3 27.7 26.5
2007 35.7 33.7 28.4 27.2 25.4
2006 36.1 33.7 27.3 26.2 30.2